Leonard Frank X 4
4 · NovoCure Ltd · Filed Jun 4, 2025
Insider Transaction Report
Form 4
NovoCure LtdNVCR
Leonard Frank X
Chief Executive Officer
Transactions
- Sale
Ordinary Shares
2025-06-02$17.99/sh−6,600$118,733→ 170,331 total - Sale
Ordinary Shares
2025-06-02$17.22/sh−21,717$373,958→ 176,931 total - Sale
Ordinary Shares
2025-06-02$19.01/sh−1,879$35,722→ 168,452 total
Footnotes (3)
- [F1]On the transaction date, pursuant to a Rule 10b5-1 trading plan adopted by the reporting person, the reporting person sold 21,717 shares in multiple trades at prices ranging from $16.71 to $17.70. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Staff, the issuer for any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
- [F2]On the transaction date, pursuant to a Rule 10b5-1 trading plan adopted by the reporting person, the reporting person sold 6,600 shares in multiple trades at prices ranging from $17.71 to $18.65. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Staff, the issuer for any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
- [F3]On the transaction date, pursuant to a Rule 10b5-1 trading plan adopted by the reporting person, the reporting person sold 1,879 shares in multiple trades at prices ranging from $18.78 to $19.03. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Staff, the issuer for any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.